Profile

Yu he-yong, senior pharmacist, master tutor, graduated from zhejiang university. He mainly engaged in drug control or release drugs targeted molecular studies and clinical pharmacology. Now he is hosting the major projects of zhejiang province “the reversal of drug-resistant tumor research before clinical”; having completed the torch-plan projects in zhejiang province “the high stability of easy absorption polypeptide protein design and application” and zhejiang health programs “the vagina bolt progestin pills in serum and endometrial concentration determination” and “the interferon millirod projects and the development of slow-release preparations”; zhejiang provincial bureau of TCM key projects “the effect of guangxi pill on model mice cytokines’ and “research and development of ointment”; and zhejiang provincial health department project “preparation and cytotoxic drug research of protective measures” such research projects etc.. In nanoparticles drug delivery system research conducted in-depth research and accumulated valuable experience, has published SCI, EI papers.
[1] Meng-Dan Zhao, Fu-Qiang Hu, Yong-Zhong Du, Hong Yuan, Feng-Ying Chen, Ya-Min Lou, He-YongYu*, Coadministration of glycolipid-like micelles loading cytotoxic drug with different action site for efficient cancer chemotherapy. Nanotechnology, 2009, 20, 055102 (10pp).
[2] Yi-Qing Ye, Feng-Liang Yang, Fu-Qiang Hu, Yong-Zhong Du, Hong Yuan, He-YongYu*, Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin
International Journal of Pharmaceutics, 2008, 352,(1-2):294-301.
[3] Yi-Qing Ye, Feng-Ying Chen, Fu-Qiang Hu, Yong-Zhong Du, Hong Yuan, He-YongYu*, Enhanced cytotoxicity of core modified chitosan based polymeric micelles for doxorubicin delivery. Journal of Pharmaceutical Sciences,2009,98:704-712.